General Announcement::Announcement by TMC Life Sciences Berhad, a subsidiary of Thomson Medical Group Limited
Issuer & Securities
THOMSON MEDICAL GROUP LIMITED
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED GRP LTD W190424 - SG5HB3000007 - CSIW
Date &Time of Broadcast
Announcement Sub Title
Announcement by TMC Life Sciences Berhad, a subsidiary of Thomson Medical Group Limited
Submitted By (Co./ Ind. Name)
Description (Please provide a detailed description of the event in the box below)
TMC Life Sciences Berhad, a subsidiary of Thomson Medical Group Limited, has made the following announcement on Bursa Malaysia on 31 October 2018:-
TMC LIFE SCIENCES BERHAD
The Company wishes to announce that BB Waterfront Sdn. Bhd. ( BBWF ), a wholly owned subsidiary of the Company had on 29 October 2018 awarded the Piling Works to Putra Perdana Construction Sdn. Bhd. for the Proposed 33-Storey Mixed Development at PTB 24075, Jalan Stulang Darat, Stulang Laut, Bandar Johor Bahru, Daerah Johor Bahru ( the Contract ) to facilitate the construction work on Thomson Iskandar Medical Hub.
The Contract period will be for a period of Forty (40) weeks, commencing on 26 November 2018 and to be completed by or before 2 September 2019.
The Contract Sum is Ringgit Malaysia Forty Eight Million Six Hundred Ninety-Six Thousand Six Hundred Twenty Eight (RM48,696,628) only.
The Board of Directors of the Company does not envisage any specific risk to be associated with the Contract, apart from the operational and financial costs.
The Contract will not have any effect on the issued and paid-up share capital of the Company and is not expected to have any material effect on the earnings, earnings per share, net asset value and gearing of TMC Group during the Contract period.
The Contract will be funded through internally-generated funds.
DIRECTORS AND MAJOR SHAREHOLDERS INTEREST
None of the Directors and/or major shareholders of the Company and/or persons connected with them, have any interest, direct or indirect, in the Contract.